Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pathologists Collaborate to Improve Reporting and Accessibility of Cancer Pathology Findings

By LabMedica International staff writers
Posted on 28 Oct 2013
A new partnership has been formed to provide an electronic application service to enhance cancer pathology reporting and use of datasets.

The College of American Pathologists (CAP; Northfield, IL, USA) and mTuitive, Inc. More...
(Centerville, MA, USA) have forged a collaboration to more effectively capture and report cancer pathology findings by providing a product and service that will facilitate production and use of standardized, encoded, and interoperable data sets for use in patient care, registries, research, and biorepositories.

Together, the CAP and mTuitive have developed “CAP eFRM” – the CAP electronic Forms and Reporting Module, an application incorporating the CAP electronic Cancer Checklists (eCC). Cancer case summaries within 65 cancer protocols are electronically represented within the eCC in addition to two new tumor biomarker reporting templates for colon and lung cancer. eFRM was now presented at the CAP’s annual meeting (CAP 2013, Orlando, FA, USA). “We designed eFRM to help pathologists and laboratories make more effective use of data electronically as they care for patients,” said Charles Roussel, CAP CEO; “This application eases eCC implementation for health care and laboratory system vendors, ultimately benefiting pathologists, laboratory professionals, clinicians, and patients.”

The American College of Surgeons - Commission on Cancer (CoC) has also recognized the value of the CAP cancer protocols and has mandated that pathologists at CoC-approved cancer programs include the required data elements of the cancer protocols in their surgical pathology reports on cancer specimens.

mTuitive's unique method of capturing and reporting structured information provides valuable data for pathology, surgery, oncology, and cancer staging applications. “We believe in and are committed to what the CAP is doing in cancer care and, through our collaboration, eFRM furthers how information technology can improve care for cancer patients,” said John Murphy, CEO, mTuitive.

The CAP and mTuitive will offer two versions of eFRM. The first is a basic, standalone version; the second includes a wider range of functionality and was designed to be integrated within a laboratory information system. Both versions will facilitate broader adoption among pathologists and help simplify the management of content changes to the cancer protocols.

Related Links:

College of American Pathologists (CAP)
mTuitive



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.